BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19729219)

  • 1. Reduced serum hepcidin levels in patients with chronic hepatitis C.
    Girelli D; Pasino M; Goodnough JB; Nemeth E; Guido M; Castagna A; Busti F; Campostrini N; Martinelli N; Vantini I; Corrocher R; Ganz T; Fattovich G
    J Hepatol; 2009 Nov; 51(5):845-52. PubMed ID: 19729219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion.
    Fujita N; Sugimoto R; Motonishi S; Tomosugi N; Tanaka H; Takeo M; Iwasa M; Kobayashi Y; Hayashi H; Kaito M; Takei Y
    J Hepatol; 2008 Nov; 49(5):702-10. PubMed ID: 18620776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low hepcidin triggers hepatic iron accumulation in patients with hepatitis C.
    Hörl WH; Schmidt A
    Nephrol Dial Transplant; 2014 Jun; 29(6):1141-4. PubMed ID: 24286977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
    Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.
    Fujita N; Sugimoto R; Takeo M; Urawa N; Mifuji R; Tanaka H; Kobayashi Y; Iwasa M; Watanabe S; Adachi Y; Kaito M
    Mol Med; 2007; 13(1-2):97-104. PubMed ID: 17515961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Duodenal Iron Absorption through Upregulation of Ferroportin 1 due to the Decrement in Serum Hepcidin in Patients with Chronic Hepatitis C.
    Sato M; Miyanishi K; Tanaka S; Sakurada A; Sakamoto H; Kawano Y; Takada K; Kobune M; Kato J
    Can J Gastroenterol Hepatol; 2018; 2018():2154361. PubMed ID: 30186818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum prohepcidin levels correlate with hepatic iron stores in chronic hepatitis C patients.
    Lin TJ; Liao LY; Chou JM; Liu SO; Wang CK
    Hepatogastroenterology; 2009; 56(93):1146-51. PubMed ID: 19760959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
    Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
    Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents.
    Inomata S; Anan A; Yamauchi E; Yamauchi R; Kunimoto H; Takata K; Tanaka T; Yokoyama K; Morihara D; Takeyama Y; Irie M; Shakado S; Sohda T; Sakisaka S
    Intern Med; 2019 Oct; 58(20):2915-2922. PubMed ID: 31243222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum hepcidin levels in patients with porphyria cutanea tarda.
    Darwich E; To-Figueras J; Molina-López RA; Deulofeu R; Olbina G; Westerman M; Sánchez-Tápias JM; Muñoz-Santos C; Herrero C
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e68-74. PubMed ID: 22429447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron overload and glucose abnormalities in chronic hepatitis C virus infection: phlebotomy lowers risk of new-onset diabetes.
    Mifuji-Moroka R; Iwasa M; Miyachi H; Sugimoto R; Tanaka H; Ishihara T; Fujita N; Kaito M; Kobayashi Y; Takei Y
    Hepatogastroenterology; 2013 Oct; 60(127):1736-41. PubMed ID: 24634944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C.
    Tsochatzis E; Papatheodoridis GV; Koliaraki V; Hadziyannis E; Kafiri G; Manesis EK; Mamalaki A; Archimandritis AJ
    J Viral Hepat; 2010 Nov; 17(11):800-6. PubMed ID: 20002304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome.
    Luque-Ramírez M; Álvarez-Blasco F; Alpañés M; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2011 Mar; 96(3):846-52. PubMed ID: 21209031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is iron overload in alcohol-related cirrhosis mediated by hepcidin?
    Iqbal T; Diab A; Ward DG; Brookes MJ; Tselepis C; Murray J; Elias E
    World J Gastroenterol; 2009 Dec; 15(46):5864-6. PubMed ID: 19998511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls.
    Costa-Matos L; Batista P; Monteiro N; Simões M; Egas C; Pereira J; Pinho H; Santos N; Ribeiro J; Cipriano MA; Henriques P; Girão F; Rodrigues A; Carvalho A
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1158-65. PubMed ID: 22732356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of serum haemojuvelin and hepcidin levels with iron level and erythropoietin requirement in prevalent hepatitis C virus positive haemodialysis patients.
    El Said HW; Abou Seif KH; Ahmed YS; Abou Elleil HA; El Said TW; Behairy MA; Mohamed MM; Ahmed FA
    Nephrology (Carlton); 2018 Apr; 23(4):323-330. PubMed ID: 28130911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease.
    Boga S; Alkim H; Alkim C; Koksal AR; Bayram M; Yilmaz Ozguven MB; Tekin Neijmann S
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):293-300. PubMed ID: 26405701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency.
    Foka P; Dimitriadis A; Karamichali E; Kyratzopoulou E; Giannimaras D; Koskinas J; Varaklioti A; Mamalaki A; Georgopoulou U
    Virulence; 2016 Aug; 7(6):679-90. PubMed ID: 27058404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.
    Zaritsky J; Young B; Wang HJ; Westerman M; Olbina G; Nemeth E; Ganz T; Rivera S; Nissenson AR; Salusky IB
    Clin J Am Soc Nephrol; 2009 Jun; 4(6):1051-6. PubMed ID: 19406957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.